Vascular Risk Factors and Dementia: 40-Year Follow-Up of a Population-Based Cohort
The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
Aims: Our aim was to evaluate the longitudinal associations of individual and multiple vascular risk factors with the subsequent development of dementia and Alzheimer’s disease (AD). Methods: The Uppsala Longitudinal Study of Adult Men started in 1970 when the 2,268 participants were 50 years old. Baseline investigations included determinations of blood pressure, fasting glucose, cholesterol, BMI and smoking status. Over a maximum follow-up of 40 years, 349 participants were diagnosed with dementia, out of which 127 had AD. Analyses were repeated using a re-examination of the cohort at 70 years of age as a baseline. Results: No associations between vascular risk factors and AD were found. For all-type dementia, the association between high systolic blood pressure and dementia was the most consistent. High fasting glucose was associated with increased risk of all-type dementia only when measured at 70 years. Individuals with both an APOE Ε4 allele and vascular risk factors had the greatest dementia risk. Conclusion: Vascular risk factors influence the future risk of dementia, in particular vascular and mixed-type rather than AD. The impact of vascular risk factors on dementia in a longitudinal study depends on the age at baseline and the length of follow-up.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“For example, midlife obesity, 105,111,112 hypertension, 85,[105][106][107] prehypertension (systolic blood pressure from 120 to 139 mm Hg or diastolic pressure from 80 to 89 mm Hg) 85 and high cholesterol 113 are associated with an increased risk of dementia in later life.”
From 2023 Alzheimer's disease facts and figures (2023) · cites this paper as [105]
In the citing paper
“These factors include hypertension 85,[105][106][107] and diabetes.[108][109][110]”
From 2023 Alzheimer's disease facts and figures (2023) · cites this paper as [105]
In the citing paper
“Many factors that increase the risk of cardiovascular disease are also associated with a higher risk of dementia. 114 These factors include hypertension, 91 , 115 , 116 , 117 diabetes 118 , 119 , 120 and smoking. 121 , 122”
From 2024 Alzheimer's disease facts and figures (2024) · cites this paper as [115]
In the citing paper
“For example, midlife obesity, 115 , 147 , 148 hypertension, 91 , 115 , 116 , 117 and high cholesterol 149 are among the midlife factors associated with an increased risk of dementia in later life.”
From 2024 Alzheimer's disease facts and figures (2024) · cites this paper as [115]
In the citing paper
“while 2 found this relationship for some outcomes but not others [97,103]”
From Epidemiologic studies of modifiable factors associated with cognition and dementia: systematic review and meta-analysis (2014) · cites this paper as [103]
Citations
Cites
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
Diagnostic and Statistical Manual of Mental Disorders (DSM-IV)
Hu, R. J. (2003) · Encyclopedia of the Neurological Sciences · doi:10.1016/b0-12-226870-9/01070-4 · Cited by 9,117
Apolipoprotein E polymorphism and atherosclerosis.
Davignon, J., Gregg, R. E., & Sing, C. F. (1988) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.8.1.1 · Cited by 1,981
Lerner, D. J., & Kannel, W. B. (1986) · American Heart Journal · doi:10.1016/0002-8703(86)90155-9 · Cited by 1,725 · cited 1×
“However, individuals with both APOE e4 and vascular risk factors certainly have the highest risk of developing dementia, irrespective of the cause.Our results are derived from a large community-based population over a long follow-up period. However, as we only examined men of the same age with a similar ethnic backgro…”
BackgroundKivipelto, M., Helkala, E.-L., Laakso, M. P., Hänninen, T., Hallikainen, M., Alhainen, K., Soininen, H., Tuomilehto, J., & Nissinen, A. (2001) · BMJ · doi:10.1136/bmj.322.7300.1447 · Cited by 1,618
McKhann, G. M. (2001) · Archives of Neurology · doi:10.1001/archneur.58.11.1803 · Cited by 1,472 · cited 1×
“frontotemporal dementia according to the McKhann criteria [”
MethodMidlife cardiovascular risk factors and risk of dementia in late life
Whitmer, R. A., Sidney, S., Selby, J., Johnston, S. C., & Yaffe, K. (2005) · Neurology · doi:10.1212/01.wnl.0000149519.47454.f2 · Cited by 1,238 · cited 1×
“Midlife vascular risk factors and late-life dementia have been studied in a number of longitudinal cohorts, but the results are far from conclusive [”
BackgroundChui, H. C., Victoroff, J. I., Margolin, D., Jagust, W., Shankle, R., & Katzman, R. (1992) · Neurology · doi:10.1212/wnl.42.3.473 · Cited by 1,201
Midlife blood pressure and dementia: the Honolulu–Asia aging study☆
Launer, L. J., Ross, G. W., Petrovitch, H., Masaki, K., Foley, D., White, L. R., & Havlik, R. J. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00096-8 · Cited by 1,008
Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging
Rowe, C. C., Ellis, K. A., Rimajova, M., Bourgeat, P., Pike, K. E., Jones, G., Fripp, J., Tochon-Danguy, H., Morandeau, L., O'Keefe, G., et al. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.04.007 · Cited by 986 · cited 1×
“Amyloid accumulation eventually leading to AD neurodegeneration starts decades before clinical symptoms emerge [”
Background
Cited by
2016 Alzheimer's disease facts and figures
Alzheimer's Association (2016) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.03.001 · Cited by 5,069
“Some studies propose that impaired glucose processing (a precursor to diabetes) may also result in an increased risk for dementia [51,58,59].”
2013 Alzheimer's disease facts and figures
Alzheimer's Association, Thies, W., & Bleiler, L. (2013) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2013.02.003 · Cited by 3,328
2023 Alzheimer's disease facts and figures
(2023) · Alzheimer's & Dementia · doi:10.1002/alz.13016 · Cited by 3,212
2024 Alzheimer's disease facts and figures
(2024) · Alzheimer's & Dementia · doi:10.1002/alz.13809 · Cited by 2,536
2019 Alzheimer’s disease facts and figures.
Alzheimer's Association (2019) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2019.01.010 · Cited by 2,461
2022 Alzheimer's disease facts and figures
(2022) · Alzheimer's & Dementia · doi:10.1002/alz.12638 · Cited by 2,341
2020 Alzheimer's disease facts and figures
(2020) · Alzheimer's & Dementia · doi:10.1002/alz.12068 · Cited by 2,353
2021 Alzheimer's disease facts and figures
(2021) · Alzheimer's & Dementia · doi:10.1002/alz.12328 · Cited by 2,201
2018 Alzheimer's disease facts and figures
Alzheimer's Association (2018) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2018.02.001 · Cited by 1,912
2015 Alzheimer's disease facts and figures
Alzheimer's Association (2015) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2015.02.003 · Cited by 1,635
2017 Alzheimer's disease facts and figures
(2017) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2017.02.001 · Cited by 1,311
“Some studies propose that impaired glucose processing (a precursor to diabetes) may also result in an increased risk for dementia [53,60,61].”
2014 Alzheimer's disease facts and figures
Alzheimer's Association (2014) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2014.02.001 · Cited by 1,020
Beydoun, M. A., Beydoun, H. A., Gamaldo, A. A., Teel, A., Zonderman, A. B., & Wang, Y. (2014) · BMC Public Health · doi:10.1186/1471-2458-14-643 · Cited by 671
“For smoking status, the common referent category was non-smoking or never smoking or « never or former » whereas exposed group consisted of either « ever smokers » [78,93], or a pooled value for RR to obtain an approximate « ever smoker » category [86], or current smokers [82,88,95], or mid-life smoking or heavy smoki…”
BackgroundInfluentialDeckers, K., van Boxtel, M. P. J., Schiepers, O. J. G., de Vugt, M., Muñoz Sánchez, J. L., Anstey, K. J., Brayne, C., Dartigues, J.-F., Engedal, K., Kivipelto, M., et al. (2015) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.4245 · Cited by 534
“Nineteen studies reported on diabetes, of which 17 found an increased effect (Alonso et al., 2009; Abbatecola et al., 2010; Crowe et al., 2010; Rastas et al., 2010; Reitz et al., 2010b; Ritchie et al., 2010; Yen et al., 2010; Cheng et al., 2011; Christman et al., 2011; Kimm et al., 2011; Mejia-Arango and Gutierrez, 20…”
BackgroundResultInfluential2025 Alzheimer's disease facts and figures
(2025) · Alzheimer's & Dementia · doi:10.1002/alz.70235 · Cited by 474
Defining the relationship between hypertension, cognitive decline, and dementia: a review
Walker, K. A., Power, M. C., & Gottesman, R. F. (2017) · Current Hypertension Reports · doi:10.1007/s11906-017-0724-3 · Cited by 394
Zhong, G., Wang, Y., Zhang, Y., Guo, J. J., & Zhao, Y. (2015) · PLOS ONE · doi:10.1371/journal.pone.0118333 · Cited by 362
Models and mechanisms of vascular dementia
Venkat, P., Chopp, M., & Chen, J. (2015) · Experimental Neurology · doi:10.1016/j.expneurol.2015.05.006 · Cited by 341
Hersi, M., Irvine, B., Gupta, P., Gomes, J., Birkett, N., & Krewski, D. (2017) · NeuroToxicology · doi:10.1016/j.neuro.2017.03.006 · Cited by 332
“, 2011a,b) and five cohort studies (Reitz et al., 2010b; Chu et al., 2010; Blasko et al., 2010; Ronnemaa et al., 2011; Yang et al., 2011) that examined the association between APOE e4 and risk of AD.”
BackgroundMethodResultInfluentialVascular Cognitive Impairment (VCI)
Rundek, T., Tolea, M., Ariko, T., Fagerli, E. A., & Camargo, C. J. (2022) · Neurotherapeutics · doi:10.1007/s13311-021-01170-y · Cited by 305
The amyloid cascade hypothesis: an updated critical review
Kepp, K. P., Robakis, N. K., Høilund-Carlsen, P. F., Sensi, S. L., & Vissel, B. (2023) · Brain · doi:10.1093/brain/awad159 · Cited by 284
Albanese, E., Launer, L. J., Egger, M., Prince, M. J., Giannakopoulos, P., Wolters, F. J., & Egan, K. (2017) · Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring · doi:10.1016/j.dadm.2017.05.007 · Cited by 272
Combining modifiable risk factors and risk of dementia: a systematic review and meta-analysis
Peters, R., Booth, A., Rockwood, K., Peters, J., D’Este, C., & Anstey, K. J. (2019) · BMJ Open · doi:10.1136/bmjopen-2018-022846 · Cited by 255
Hypertension, Brain Damage and Cognitive Decline
Gąsecki, D., Kwarciany, M., Nyka, W., & Narkiewicz, K. (2013) · Current Hypertension Reports · doi:10.1007/s11906-013-0398-4 · Cited by 211
Tau Biology and Tau-Directed Therapies for Alzheimer’s Disease
Bakota, L., & Brandt, R. (2016) · Drugs · doi:10.1007/s40265-015-0529-0 · Cited by 170
“Other risk factors include the apolipoprotein e4 allele [2, 3], cardiovascular disease risk factors [4, 5], inflammation [6]”
BackgroundSelf‐reported sleep disturbance is associated with Alzheimer's disease risk in men
Benedict, C., Byberg, L., Cedernaes, J., Hogenkamp, P. S., Giedratis, V., Kilander, L., Lind, L., Lannfelt, L., & Schiöth, H. B. (2015) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2014.08.104 · Cited by 160
“Dementia was assessed as described earlier [10].”
Self-citationHypertension and cognitive dysfunction in elderly: blood pressure management for this global burden
Tadić, M., Cuspidi, C., & Hering, D. (2016) · BMC Cardiovascular Disorders · doi:10.1186/s12872-016-0386-0 · Cited by 194
Calabrese, V., Giordano, J., Signorile, A., Laura Ontario, M., Castorina, S., De Pasquale, C., Eckert, G., & Calabrese, E. J. (2016) · Journal of Neuroscience Research · doi:10.1002/jnr.23925 · Cited by 157
“Vascular risk factors influence the future risk of dementia, particularly VaD (Ronnemaa et al., 2011).”
BackgroundMeng, X.-F., Yu, J.-T., Wang, H.-F., Tan, M.-S., Wang, C., Tan, C.-C., & Tan, L. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-140954 · Cited by 150
Chui, H. C., Zheng, L., Reed, B. R., Vinters, H. V., & Mack, W. J. (2011) · Alzheimer's Research & Therapy · doi:10.1186/alzrt98 · Cited by 141
“…risk profi le: DBP <70, pulse pressure <70, heart failure 1 ≥2 1.15 (0.90, 1.47)f 1.88 (1.30, 2.70)f 1.27 (0.96, 1.69)f 2.06 (1.31, 3.34)f B2 Ronnemaa et al. 2011 [3]; Uppsala 49.6 ± 0.6 29 SBP >140 mmHg, BMI >28, fasting glucose >7 mmol/L, cholesterol >7mmol/L, current…”
BackgroundResultInfluentialMidlife Vascular Risk Factors and Alzheimer's Disease: Evidence from Epidemiological Studies
Tolppanen, A.-M., Solomon, A., Soininen, H., & Kivipelto, M. (2012) · Journal of Alzheimer's Disease · doi:10.3233/jad-2012-120802 · Cited by 136
“Similar conclusions were drawn from studies using other cutoffs [22, 37], although two large mid-life cohort studies found no [24, 38].”
Olsson, E., Byberg, L., Karlström, B., Cederholm, T., Melhus, H., Sjögren, P., & Kilander, L. (2017) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.116.141531 · Cited by 126
Self-citationRedox proteomics and amyloid β-peptide: Insights into Alzheimer disease
Butterfield, D. A., & Boyd‐Kimball, D. (2019) · Journal of Neurochemistry · doi:10.1111/jnc.14589 · Cited by 105
“…Gottesman et al. 2017a), diabetes (Wu et al. 2008; Reitz et al. 2011; Gudala et al. 2013; Vagelatos and Eslick 2013), impaired glucose metabolism (R€onnemaa et al. 2011; Crane et al. 2013), hyperlipidemia (Soloman et al. 2009; Meng et al. 2014), and hypertension (Launer et al. 2000; Debette et…”
BackgroundIs Vasomotion in Cerebral Arteries Impaired in Alzheimer’s Disease?
Di Marco, L. Y., Farkas, E., Martin, C., Venneri, A., & Frangi, A. F. (2015) · Journal of Alzheimer's Disease · doi:10.3233/jad-142976 · Cited by 95
Nagata, K., Yamazaki, T., Takano, D., Maeda, T., Fujimaki, Y., Nakase, T., & Sato, Y. (2016) · Ageing Research Reviews · doi:10.1016/j.arr.2016.06.001 · Cited by 107
Dietary Patterns and Cognitive Dysfunction in a 12-Year Follow-up Study of 70 Year Old Men
Olsson, E., Karlström, B., Kilander, L., Byberg, L., Cederholm, T., & Sjögren, P. (2014) · Journal of Alzheimer's Disease · doi:10.3233/jad-140867 · Cited by 92
“Cases of dementia without neuroimaging and/or sufficient clinical details in medical records to set a specific subtype diagnosis were classified as unspecified dementia [38].”
Self-citationRen, L., Zheng, Y., Wu, L., Gu, Y., He, Y., Jiang, B., Zhang, J., Zhang, L., & Li, J. (2018) · Scientific Reports · doi:10.1038/s41598-018-21983-w · Cited by 104
Wee, J., Sukudom, S., Bhat, S., Marklund, M., Peiris, N. J., Hoyos, C. M., Patel, S., Naismith, S. L., Dwivedi, G., & Misra, A. (2023) · Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring · doi:10.1002/dad2.12395 · Cited by 82
Qin, J., He, Z., Wu, L., Wang, W. “., Lin, Q., Lin, Y., & Zheng, L. (2021) · Hypertension Research · doi:10.1038/s41440-021-00704-3 · Cited by 95
“As an established risk factor for cerebrovascular disease, emerging evidence has demonstrated that hypertension has an important influence on the development of cognitive impairment, vascular dementia, and Alzheimer’s disease (AD) [6, 7].”
BackgroundRobert, J., Stukas, S. K., Button, E. B., Cheng, W. H., Lee, M., Fan, J., Wilkinson, A., Kulić, I., Wright, S. D., & Wellington, C. L. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.10.005 · Cited by 98
Hoscheidt, S. M., Kellawan, J. M., Berman, S. E., Rivera‐Rivera, L. A., Krause, R. A., Oh, J. M., Beeri, M. S., Rowley, H. A., Wieben, O. E., Carlsson, C. M., et al. (2016) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x16663214 · Cited by 75
Scuteri, A., Benetos, A., Sierra, C., Coca, A., Chicherio, C., Frisoni, G. B., Gąsecki, D., Hering, D., Lović, D. B., Manios, E. D., et al. (2020) · Journal of Hypertension · doi:10.1097/hjh.0000000000002621 · Cited by 75
Apolipoprotein B is a novel marker for early tau pathology in Alzheimer's disease
Picard, C., Nilsson, N., Labonté, A., Auld, D., Rosa‐Neto, P., Initiative, T. A. D. N., Ashton, N. J., Zetterberg, H., Blennow, K., Breitner, J. C. B., et al. (2022) · Alzheimer's & Dementia · doi:10.1002/alz.12442 · Cited by 66
Soh, Y., Whitmer, R. A., Mayeda, E. R., Glymour, M. M., Peterson, R. L., Eng, C. W., Quesenberry, C. P., Manly, J. J., & Gilsanz, P. (2023) · JAMA Neurology · doi:10.1001/jamaneurol.2022.5337 · Cited by 65
Diabetes and cognitive decline
Bellia, C., Lombardo, M., Meloni, M., Della‐Morte, D., Bellia, A., & Lauro, D. (2022) · Advances in clinical chemistry · doi:10.1016/bs.acc.2021.07.006 · Cited by 65
Tolppanen, A.-M., Lavikainen, P., Solomon, A., Kivipelto, M., Uusitupa, M. I. J., Soininen, H. S., & Hartikainen, S. A. (2013) · Diabetes Care · doi:10.2337/dc12-1287 · Cited by 66
“vascular risk factors may also be a more accurate reflection of the vascular load during adulthood (40).”
BackgroundStrand, B. H., Langballe, E. M., Hjellvik, V., Handal, M., Næss, Ø., Knudsen, G. P., Refsum, H., Tambs, K., Nafstad, P. H. J., Schirmer, H., et al. (2012) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2012.10.018 · Cited by 54
“However, several recent studies failed to find an association between hypertension and AD [25–27].”
BackgroundThe Anti-Amyloid Monoclonal Antibody Lecanemab: 16 Cautionary Notes
Kepp, K. P., Sensi, S. L., Johnsen, K. B., Barrio, J. R., Høilund-Carlsen, P. F., Neve, R. L., Alavi, A., Herrup, K., Perry, G., Robakis, N. K., et al. (2023) · Journal of Alzheimer's Disease · doi:10.3233/jad-230099 · Cited by 53
Nasoohi, S., Parveen, K., & Ishrat, T. (2018) · Journal of Alzheimer’s Disease · doi:10.3233/jad-180735 · Cited by 50
“Existingevidencealsopostulates T2DMandADsharesomeetiologicalfeatures,of whichincreasedcirculatingglucoseandlipidsorthe progressiveinsulinresistancemaydirectlyinstigate deterioratingeffectorsescalatingrisksfordementia andADdevelopment[25,26].”
Hagström, E., Kilander, L., Nylander, R., Larsson, E., Michaëlsson, K., Melhus, H., Ahlström, H. K., Johansson, L. O. M., Lind, L., & Ärnlöv, J. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-1736 · Cited by 48
Self-citationGenetic Biomarkers on Age-Related Cognitive Decline
Lin, C., Lin, E., & Lane, H. (2017) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2017.00247 · Cited by 56
Liu, C., Lin, M.-H., Peng, L., Chen, L., Su, C.-T., Liu, L.-K., & Chen, L. Y. (2013) · The journal of nutrition health & aging · doi:10.1007/s12603-013-0010-2 · Cited by 50
Uemura, M. T., Ihara, M., Maki, T., Nakagomi, T., Kaji, S., Uemura, K., Matsuyama, T., Kalaria, R. N., Kinoshita, A., & Takahashi, R. (2017) · Brain Pathology · doi:10.1111/bpa.12523 · Cited by 47
“However, vascular risk factors are related to a lesser degree to a pure type of AD (10, 38) or mixed type (AD with vascular pathology) dementia (23) compared with vascular cognitive impairment.”
BackgroundMunoz, N., Litchford, M., Cox, J., Nelson, J. L., Nie, A. M., & Delmore, B. (2022) · Advances in Skin & Wound Care · doi:10.1097/01.asw.0000816332.60024.05 · Cited by 57
Associations of serum uric acid with incident dementia and cognitive decline in the ARIC-NCS cohort
Alam, A. B., Wu, A., Power, M. C., West, N. A., & Alonso, Á. (2020) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2020.116866 · Cited by 49
Ren, L., Bai, L., Wu, Y., Ni, J., Shi, M., Lu, H., Tu, J., Ning, X., Lei, P., & Wang, J. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00062 · Cited by 47
“…shown a negative correlation between BP and cognition (Kivipelto et al., 2001; Whitmer et al., 2005; Peters et al., 2008; Gao et al., 2009; Oveisgharan and Hachinski, 2010; Higuchi et al., 2015), although some studies have shown that they were not related (Rönnemaa et al., 2011; Yang et al., 2011).”
Result2026 Alzheimer's disease facts and figures
(2026) · Alzheimer s & Dementia · doi:10.1002/alz.71345 · Cited by 118
Smoking cessation and incident dementia in elderly Japanese: the Ohsaki Cohort 2006 Study
Lu, Y., Sugawara, Y., Zhang, S., Tomata, Y., & Tsuji, I. (2020) · European Journal of Epidemiology · doi:10.1007/s10654-020-00612-9 · Cited by 44
Jeon, S. Y., Byun, M. S., Yi, D., Lee, J. H., Choe, Y. M., Ko, K., Sohn, B. K., Choi, H. J., Lee, J., & Lee, D. Y. (2018) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2018.11.001 · Cited by 45
Sibbett, R. A., Russ, T. C., Deary, I. J., & Starr, J. M. (2017) · BMC Psychiatry · doi:10.1186/s12888-017-1366-3 · Cited by 38
“Significant modifiable risk factors for dementia demonstrated by replication within the literature include: diabetes [6], hypertension [7], hypercholesterolaemia [8], depression [9], smoking [10, 11], obesity [11].”
BackgroundZhang, H., Wang, P., Xue, Y., Liu, L., Li, Z., & Liu, Y. (2017) · Tissue and Cell · doi:10.1016/j.tice.2017.11.002 · Cited by 42
Zhang, N., Xing, M., Wang, Y., Liang, H., Yang, Z. R., Shi, F., & Cheng, Y. (2013) · Neuroscience Bulletin · doi:10.1007/s12264-013-1375-2 · Cited by 39
“It is the second most common cause of dementia in the elderly after Alzheimer’s disease, causing 20–30% of all elderly dementia cases([1]), while an increasing number of studies suggest an even higher percentage of elderly dementia caused by VaD([2]).”
Perdoncin, M., Konrad, A., Wyner, J. R., Lohana, S., Pillai, S. S., Pereira, D. G., Lakhani, H. V., & Sodhi, K. (2021) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2021.756499 · Cited by 40
Welberry, H., Tisdell, C. C., Huque, M. H., & Jorm, L. R. (2023) · American Journal of Epidemiology · doi:10.1093/aje/kwad138 · Cited by 37
High salt induced hypertension leads to cognitive defect
Guo, C., Wei, Z. C., Huang, F., Qin, M., Li, X., Wang, Y.-M., Wang, Q., Wang, J., Liu, R., Zhang, B., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.21326 · Cited by 35
Pathogenetic Mechanisms of Hypertension–Brain-Induced Complications: Focus on Molecular Mediators
Chiara, T. D., Cuore, A. D., Daidone, M., Scaglione, S., Norrito, R. L., Puleo, M. G., Scaglione, R., Pinto, A. V., & Tuttolomondo, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23052445 · Cited by 41
Dias, I. H. K., Brown, C. L., Shabir, K., Polidori, M. C., & Griffiths, H. R. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-180201 · Cited by 37
“Vascular risk factors appear to influence the future risk of dementia, in particular vascular and mixedtype AD [36] but no clear effects of lipid-lowering or anti-inflammatory interventions are evident in patients with established disease.”
BackgroundBlood pressure and Alzheimer's disease: A review of meta-analysis
Saiz-Vázquez, O., Puente-Martínez, A., Pacheco, J., & Landa, S. U. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2022.1065335 · Cited by 36
Paeoniflorin attenuates hippocampal damage in a rat model of vascular dementia
Zhang, Y., Wang, L., Wu, Y., Wang, N., Wang, S.-M., Zhang, B., Shi, C., & Zhang, S. (2016) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2016.3849 · Cited by 31
“Vascular dementia (VD) is the second most common type of dementia after Alzheimer's disease (1,2).”
NT-proBNP and the Risk of Dementia: A Prospective Cohort Study with 14 Years of Follow-Up
Tynkkynen, J., Laatikainen, T. K., Salomaa, V. V., Havulinna, A. S., Blankenberg, S., Zeller, T., & Hernesniemi, J. A. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-141809 · Cited by 31
“diabetes and high blood glucose [1, 2], high blood pressure [3, 4], smoking [5, 6], and hypercholesterolemia [7] are also risk factors for dementia.”
BackgroundPredictors of Independent Aging and Survival: A 16‐Year Follow‐Up Report in Octogenarian Men
Franzon, K., Byberg, L., Sjögren, P., Zethelius, B., Cederholm, T., & Kilander, L. (2017) · Journal of the American Geriatrics Society · doi:10.1111/jgs.14971 · Cited by 30
“9 Waist circumference, cm, n (%) <94 503 (46) 297 (48) 180 (49) 94–102 393 (36) 224 (36) 135 (37) >102 194 (18) 95 (15) 52 (14) Mediterranean-like diet adherence, n (%) Low 246 (22) 129 (21) 70 (19) Medium 713 (65) 405 (65) 246 (67) High 145 (13) 91 (15) 53 (14) Charlson Comorbidity Index, n (%) 0 776 (70) 485 (78) 29…”
Self-citationLin, E., Tsai, S., Kuo, P., Liu, Y., Yang, A. C., Kao, C., & Yang, C. (2017) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000455833 · Cited by 28
Gu, Y., Liu, R., Qin, R., Chen, X., Zou, J., Jiang, Y., Ye, Q., Zhang, B., Bai, F., & Xu, Y. (2018) · Hypertension Research · doi:10.1038/s41440-018-0176-4 · Cited by 28
Favorable Cardiovascular Health at Young and Middle Ages and Dementia in Older Age—The CHA Study
Vu, T. T., Zhao, L., Liu, L., Schiman, C., Lloyd‐Jones, D. M., Daviglus, M. L., Liu, K., Garside, D. B., Stamler, J., Fries, J. F., et al. (2018) · Journal of the American Heart Association · doi:10.1161/jaha.118.009730 · Cited by 27
Martínez‐Cué, C., & Rueda, N. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186906 · Cited by 26
The central histamine level in rat model of vascular dementia.
Stasiak, A., Mussur, M., Unzeta, M., Łażewska, D., Kieć‐Kononowicz, K., & Fogel, W. A. (2011) · PubMed · Cited by 29
Prajjwal, P., Marsool, M. D. M., Inban, P., Sharma, B., Asharaf, S., Aleti, S., Gadam, S., Sakini, A. S. A., & Hadi, D. D. (2023) · Disease-a-Month · doi:10.1016/j.disamonth.2023.101557 · Cited by 32
Assessment of risk factors for earlier onset of sporadic Alzheimer′s disease dementia
de Oliveira, F. F., Bertolucci, P. H. F., Chen, E., & Smith, M. D. A. C. (2014) · Neurology India · doi:10.4103/0028-3886.149384 · Cited by 27
Tan, X. W., Sundström, J., Lind, L., Franzon, K., Kilander, L., & Benedict, C. (2021) · Hypertension · doi:10.1161/hypertensionaha.120.16711 · Cited by 29
Self-citationAlzheimer's disease knowledge among American Indians and Alaska Natives
Jernigan, M., Boyd, A. D., Noonan, C., & Buchwald, D. (2020) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1002/trc2.12101 · Cited by 26
Dick, O. E., & Glazov, A. L. (2021) · Neurocomputing · doi:10.1016/j.neucom.2021.05.038 · Cited by 25
Smoking and Risk for Alzheimer Disease: A Meta-Analysis Based on Both Case-Control and Cohort Study
Niu, H., Qu, Y., Li, Z., Wang, R., Li, L., Li, M., Lv, X., Gao, C., Song, Y., & Li, B. (2018) · The Journal of Nervous and Mental Disease · doi:10.1097/nmd.0000000000000859 · Cited by 23
Lundin, S. K., Hu, X., Feng, J., Lundin, K. K., Li, L., Chen, Y., Schulz, P. E., & Tao, C. (2024) · EBioMedicine · doi:10.1016/j.ebiom.2024.105378 · Cited by 27
Vascular neurocognitive disorders and the vascular risk factors
Albu, C. V., Pădureanu, V., Boldeanu, M. V., Bumbea, A. M., Enescu, A. Ş., Albulescu, D. M., Siloşi, C. A., & Enescu, A. (2018) · Journal of Mind and Medical Sciences · doi:10.22543/7674.51.p715 · Cited by 23
“Cranial CT scans on hypertensive patients have revealed a cortical atrophy or leukoaraiosis at the level of the hippocampus (30, 31).”
BackgroundFDG PET and cognitive symptoms of dementia
Perani, D. (2013) · Clinical and Translational Imaging · doi:10.1007/s40336-013-0029-8 · Cited by 20
“In the very frequent mixed forms of cognitive decline or dementia [83], an integrated MRI/PET approach will allow, in a single session, assessment of cerebrovascular changes and of the metabolic patterns of neuronal injury as the established sensitive and specific markers of neurodegeneration.”
BackgroundQiu, S.-D., Zhang, D. L., Ma, L.-Y., Li, Q., Wang, L.-Y., Wang, Y.-D., Wang, Y.-C., Xiong, S.-Y., & Tan, L. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251326553 · Cited by 26
“70,71 Hypertension has been shown to exacerbate AD neuropathology by inducing cerebrovascular dysfunction, which in turn stimulates A β production.”
Cardiovascular Risk Factors and Risk of Alzheimer Disease and Mortality: A Latent Class Approach
Ruthirakuhan, M. T., Cogo‐Moreira, H., Swardfager, W., Herrmann, N., Lanctôt, K. L., & Black, S. E. (2022) · Journal of the American Heart Association · doi:10.1161/jaha.122.025724 · Cited by 24
“18– 22 However, it is important to note that individuals in the reference group had low probabilities of CVRFs and were not completely void of CVRFs.”
Dong, H., Guo, L., Yang, H., Zhu, W., Liu, F., Xie, Y., Zhang, Y., Xue, K., Li, Q., Liang, M., et al. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1129051 · Cited by 22
“Recently, researchers found that multiple modifiable risk factors like hypoperfusion, cardiovascular disease, physical activity, diet, education, social and cognitive engagement, and traumatic brain injury increased the development and progression of AD (Sando et al., 2008; Ronnemaa et al., 2011; Rusanen et al., 2011;…”
BackgroundLyon, M., Fullerton, J. L., Kennedy, S., & Work, L. M. (2023) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2023.108575 · Cited by 24
Franzon, K., Zethelius, B., Cederholm, T., & Kilander, L. (2015) · Journal of the American Geriatrics Society · doi:10.1111/jgs.13352 · Cited by 20
Self-citationHashmi, M. U., Ahmed, R., Mahmoud, S., Ahmed, K., Bushra, N. M., Ahmed, A., Elwadie, B., Madni, A., Saad, A. B., & Abdelrahman, N. G. (2023) · Cureus · doi:10.7759/cureus.46732 · Cited by 24
Ekström, C., Puhto, I., & Kilander, L. (2021) · Upsala Journal of Medical Sciences · doi:10.48101/ujms.v126.7819 · Cited by 16
Self-citationAlzheimer’s Disease Is Associated with a Low Prevalence of Hypertension
Kuyumcu, M. E., Yeşil, Y., Öztürk, Z. A., Halil, M. G., Ülger, Z., Doğu, B. B., Cankurtaran, M., Çınar, E., & Arıoğul, S. (2012) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000336053 · Cited by 14
Nylander, R., Kilander, L., Ahlström, H. K., Lind, L., & Larsson, E. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00217 · Cited by 13
Self-citationCholesterol in midlife increases the risk of Alzheimer's disease during an up to 43-year follow-up
Rantanen, K. K., Strandberg, A. Y., Pitkälä, K. H., Tilvis, R. S., Salomaa, V. V., & Strandberg, T. E. (2014) · European Geriatric Medicine · doi:10.1016/j.eurger.2014.05.002 · Cited by 13
Alzheimer’s: A Progressive Brain Disease: Causes, Symptoms, and Prevention
Amin, F., Shamsi, A., Asghar, M. N., Khaki, P. S. S., Khan, M. S., Tabrez, S. S. M., Zaidi, S. K., Khan, W., & Bano, B. (2019) · Springer eBooks · doi:10.1007/978-981-13-9636-6_2 · Cited by 15
Liu, J., Huang, Y., Chen, G., Liu, X., Wang, Z. K., Cao, Y., Li, H., Song, L., Li, C., Zhao, H., et al. (2016) · Medicine · doi:10.1097/md.0000000000005514 · Cited by 13
“Higher cumulative exposure to SBP (per SD increment) was independently associated with poor cognitive performance after controlling for multiple factors (P 0.001).”
BackgroundInfluentialCognitive function in very old men does not correlate to biomarkers of Alzheimer’s disease
Veličkaitė, V., Giedraitis, V., Ström, K., Alafuzoff, I. I., Zetterberg, H., Lannfelt, L., Kilander, L., Larsson, E., & Ingelsson, M. (2017) · BMC Geriatrics · doi:10.1186/s12877-017-0601-6 · Cited by 14
“These men had all undergone extensive examinations at approximately 50, 60, 70, 77, 82 and 88 years of age [21, 22].”
BackgroundMethodSelf-citationHwangbo, S., Kim, Y. J., Park, Y. H., Kim, H. J., Na, D. L., Jang, H., & Seo, S. W. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.934149 · Cited by 10
“Many studies have suggested that vascular risk factors increase the development of dementia, especially SVaD (Launer et al., 2000; Kivipelto et al., 2005; Duron and Hanon, 2008; Rönnemaa et al., 2011; Caruso et al., 2019; Moretti and Caruso, 2020; Malik et al., 2021).”
BackgroundJeong, S., Lin, L., Pascual‐Leone, Á., & Hsu, Y. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251326107 · Cited by 14
“For instance, midlife obesity, 44 hypertension, 43 and high cholesterol 45 are among the midlife factors associated with an increased risk of dementia in later life.”
Metadata
- Authors
- Rönnemaa, E., Zethelius, B., Lannfelt, L., & Kilander, L.
- Affiliations
- Uppsala University (SE)
- Venue
- Dementia and Geriatric Cognitive Disorders
- Publisher
- S. Karger AG
- Published
- 2011
- Volume
- 31
- Issue
- 6
- Pages
- 460-466
- ISSN
- 1420-8008 (ISSN-L)
- 1421-9824
- OpenAlex
- W2019386454
- Cited by
- 171
- References
- 31
- Citations by year
- 2026: 11 · 2025: 10 · 2024: 11 · 2023: 15 · 2022: 11 · 2021: 12 · 2020: 9 · 2019: 10 · 2018: 14 · 2017: 18 · 2016: 13 · 2015: 12 · 2014: 9 · 2013: 9 · 2012: 4
- FWCI
- 5.47
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.karger.com/Services/SiteLicenses (vor)
- www.karger.com/Services/SiteLicenses (tdm)
- Locations
- Dementia and Geriatric Cognitive Disorders (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Risk Factors
- Keywords
- vascular risk factors, dementia, Alzheimer's disease, systolic blood pressure, fasting blood glucose, APOE ε4, vascular dementia, age at baseline, cohort follow-up
- MeSH terms
- Aged, Apolipoproteins E, Blood Glucose, Blood Pressure, Cardiovascular Diseases, Cholesterol, Data Interpretation, Statistical, Dementia, Humans, Male, Middle Aged, Population, Risk Factors, Smoking, Sweden, Cohort Studies, Body Mass Index, Proportional Hazards Models
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.